Our experts

richard-birnie

Richard Birnie, PhD

Head of Advanced Analytics (VP)

Richard joined BresMed in 2017 and has over 5 years of experience in health outcomes statistics, systematic reviews, meta-analysis, evidence-based medicine and survival analyses. Before moving into the field of health technology assessment (HTA), Richard worked as a research scientist; he has a PhD in molecular biology and has studied a wide range of different cancers including prostate, colorectal and medulloblastoma. Richard brings a strong understanding of fundamental biological principles in oncology and experience across a range of disease areas including ophthalmology and multiple sclerosis. He has been responsible for statistical input to HTA submissions, including survival and utility analysis. He has also worked as part of an Evidence Review Group on behalf of NICE, reviewing UK HTA submissions.

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies